Clinical Trials Browser

Phase 2/3 × Recruiting × Polycystic Ovary Syndrome × Clear all

NCT06896981 2025-04-02

Semaglutide in Women With Polycystic Ovary Syndrome and Obesity

Phase 2/3 Recruiting

Obesity, Polycystic Ovary Syndrome